{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T02:49:42Z","timestamp":1768531782404,"version":"3.49.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["452655"],"award-info":[{"award-number":["452655"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011094","name":"Public Health Agency of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011094","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.jtha.2023.06.026","type":"journal-article","created":{"date-parts":[[2023,6,30]],"date-time":"2023-06-30T15:40:21Z","timestamp":1688139621000},"page":"2833-2843","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Antibodies against platelet factor 4 and the risk of cerebral venous sinus thrombosis in patients with vaccine-induced immune thrombotic thrombocytopenia"],"prefix":"10.1016","volume":"21","author":[{"given":"Angela","family":"Huynh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald M.","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikola","family":"Ivetic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rumi","family":"Clare","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milena","family":"Hadzi-Tosev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James W.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna-Lise","family":"Bissola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mercy","family":"Daka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John G.","family":"Kelton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ishac","family":"Nazy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2023.06.026_bib1","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1056\/NEJMoa2104840","article-title":"Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination","volume":"384","author":"Greinacher","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2023.06.026_bib2","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1056\/NEJMoa2104882","article-title":"Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination","volume":"384","author":"Schultz","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2023.06.026_bib3","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1056\/NEJMoa2105385","article-title":"Pathologic antibodies to platelet factor 4 after ChAdOx1 nCoV-19 vaccination","volume":"384","author":"Scully","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2023.06.026_bib4","doi-asserted-by":"crossref","first-page":"e2136","DOI":"10.1212\/WNL.0000000000012896","article-title":"Cerebral venous sinus thrombosis and thrombotic events after vector-based COVID-19 vaccines: a systematic review and meta-analysis","volume":"97","author":"Palaiodimou","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.jtha.2023.06.026_bib5","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1001\/jama.2021.7517","article-title":"US case reports of cerebral venous sinus thrombosis with thrombocytopenia after Ad26.COV2.S vaccination, March 2 to April 21, 2021","volume":"325","author":"See","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.jtha.2023.06.026_bib6","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1001\/jamaneurol.2021.3619","article-title":"Characteristics and outcomes of patients with cerebral venous sinus thrombosis in SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia","volume":"78","author":"Sanchez van Kammen","year":"2021","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.jtha.2023.06.026_bib7","doi-asserted-by":"crossref","first-page":"4228","DOI":"10.1182\/bloodadvances.2022007766","article-title":"The clinical and laboratory diagnosis of vaccine-induced immune thrombotic thrombocytopenia","volume":"6","author":"Bissola","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2023.06.026_bib8","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1182\/blood.V72.3.925.bloodjournal723925","article-title":"Heparin-induced thrombocytopenia: laboratory studies","volume":"72","author":"Kelton","year":"1988","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.06.026_bib9","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1056\/NEJM200104263441704","article-title":"Temporal aspects of heparin-induced thrombocytopenia","volume":"344","author":"Warkentin","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2023.06.026_bib10","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1055\/s-0038-1651670","article-title":"Antibodies to macromolecular platelet factor 4-heparin complexes in heparin-induced thrombocytopenia: a study of 44 cases","volume":"73","author":"Amiral","year":"1995","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.06.026_bib11","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1161\/01.ATV.0000238350.89477.88","article-title":"Close approximation of two platelet factor 4 tetramers by charge neutralization forms the antigens recognized by HIT antibodies","volume":"26","author":"Greinacher","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jtha.2023.06.026_bib12","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/jth.14369","article-title":"Characterization of platelet factor 4 amino acids that bind pathogenic antibodies in heparin-induced thrombocytopenia","volume":"17","author":"Huynh","year":"2019","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.06.026_bib13","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1182\/blood.V83.11.3232.3232","article-title":"Immunoglobulin G from patients with heparin-induced thrombocytopenia binds to a complex of heparin and platelet factor 4","volume":"83","author":"Kelton","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.06.026_bib14","doi-asserted-by":"crossref","first-page":"3691","DOI":"10.1182\/blood.V84.11.3691.bloodjournal84113691","article-title":"Sera from patients with heparin-induced thrombocytopenia generate platelet-derived microparticles with procoagulant activity: an explanation for the thrombotic complications of heparin-induced thrombocytopenia","volume":"84","author":"Warkentin","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.06.026_bib15","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41586-021-03744-4","article-title":"Antibody epitopes in vaccine-induced immune thrombotic thrombocytopaenia","volume":"596","author":"Huynh","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.jtha.2023.06.026_bib16","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1182\/bloodadvances.2022007336","article-title":"Characteristics of VITT antibodies in patients vaccinated with Ad26.COV2.S","volume":"7","author":"Huynh","year":"2023","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2023.06.026_bib17","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1056\/NEJMoa2107051","article-title":"Adjunct immune globulin for vaccine-induced immune thrombotic thrombocytopenia","volume":"385","author":"Bourguignon","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2023.06.026_bib18","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1111\/jth.13066","article-title":"Distinguishing between anti-platelet factor 4\/heparin antibodies that can and cannot cause heparin-induced thrombocytopenia","volume":"13","author":"Nazi","year":"2015","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.06.026_bib19","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1080\/09537104.2017.1378808","article-title":"Development of a high-yield expression and purification system for platelet factor 4","volume":"29","author":"Huynh","year":"2018","journal-title":"Platelets"},{"key":"10.1016\/j.jtha.2023.06.026_bib20","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1182\/blood.V67.1.27.27","article-title":"A\u00a0diagnostic test for heparin-induced thrombocytopenia","volume":"67","author":"Sheridan","year":"1986","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.06.026_bib21","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1046\/j.1365-2141.1996.d01-1876.x","article-title":"The epitope specificity of heparin-induced thrombocytopenia","volume":"95","author":"Horsewood","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2023.06.026_bib22","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.tmrv.2006.05.001","article-title":"Testing for heparin-induced thrombocytopenia antibodies","volume":"20","author":"Warkentin","year":"2006","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.jtha.2023.06.026_bib23","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.4049\/jimmunol.1800323","article-title":"Qualified biolayer interferometry avidity measurements distinguish the heterogeneity of antibody interactions with Plasmodium falciparum circumsporozoite protein antigens","volume":"201","author":"Dennison","year":"2018","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jtha.2023.06.026_bib24","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ab.2013.07.025","article-title":"Off-rate screening for selection of high-affinity anti-drug antibodies","volume":"441","author":"Ylera","year":"2013","journal-title":"Anal Biochem"},{"key":"10.1016\/j.jtha.2023.06.026_bib25","doi-asserted-by":"crossref","first-page":"3250","DOI":"10.1182\/blood.V92.9.3250","article-title":"Defining an antigenic epitope on platelet factor 4 associated with heparin-induced thrombocytopenia","volume":"92","author":"Ziporen","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.06.026_bib26","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1111\/jth.13786","article-title":"5B9, a monoclonal antiplatelet factor 4\/heparin IgG with a human Fc fragment that mimics heparin-induced thrombocytopenia antibodies","volume":"15","author":"Kizlik-Masson","year":"2017","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.06.026_bib27","doi-asserted-by":"crossref","first-page":"8277","DOI":"10.1038\/ncomms9277","article-title":"Atomic description of the immune complex involved in heparin-induced thrombocytopenia","volume":"6","author":"Cai","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.jtha.2023.06.026_bib28","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1182\/blood.V99.4.1230","article-title":"Defining a second epitope for heparin-induced thrombocytopenia\/thrombosis antibodies using KKO, a murine HIT-like monoclonal antibody","volume":"99","author":"Li","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.06.026_bib29","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1146\/annurev.iy.02.040184.000435","article-title":"The antigenic structure of proteins: a reappraisal","volume":"2","author":"Benjamin","year":"1984","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jtha.2023.06.026_bib30","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1006\/meth.1996.0058","article-title":"Site-directed mutagenesis in epitope mapping","volume":"9","author":"Benjamin","year":"1996","journal-title":"Methods"},{"key":"10.1016\/j.jtha.2023.06.026_bib31","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1182\/blood.2021014588","article-title":"Monoclonal and oligoclonal anti-platelet factor 4 antibodies mediate VITT","volume":"140","author":"Kanack","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.06.026_bib32","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1111\/jth.15848","article-title":"Variable serotonin release assay pattern and specificity of PF4-specific antibodies in hit, and clinical relevance","volume":"20","author":"Rollin","year":"2022","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.06.026_bib33","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1111\/j.1538-7836.2008.03025.x","article-title":"Quantitative interpretation of optical density measurements using PF4-dependent enzyme-immunoassays","volume":"6","author":"Warkentin","year":"2008","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.06.026_bib34","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1080\/09537104.2017.1366973","article-title":"Spontaneous HIT syndrome post-knee replacement surgery with delayed recovery of thrombocytopenia: a case report and literature review","volume":"28","author":"Poudel","year":"2017","journal-title":"Platelets"},{"key":"10.1016\/j.jtha.2023.06.026_bib35","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/s44161-021-00017-1","article-title":"Foudroyant cerebral venous (sinus) thrombosis triggered through CLEC-2 and GPIIb\/IIIa dependent platelet activation","volume":"1","author":"Stegner","year":"2022","journal-title":"Nat Cardiovasc Res"},{"key":"10.1016\/j.jtha.2023.06.026_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.834988","article-title":"Signaling through FcgammaRIIA and the C5a-C5aR pathway mediate platelet hyperactivation in COVID-19","volume":"13","author":"Apostolidis","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtha.2023.06.026_bib37","article-title":"Eye-neck integrated ultrasound in idiopathic intracranial hypertension and cerebral venous sinus thrombosis","volume":"12","author":"Liu","year":"2021","journal-title":"Front Neurol"},{"key":"10.1016\/j.jtha.2023.06.026_bib38","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1136\/practneurol-2019-002415","article-title":"Cerebral venous thrombosis: a practical guide","volume":"20","author":"Ulivi","year":"2020","journal-title":"Pract Neurol"},{"key":"10.1016\/j.jtha.2023.06.026_bib39","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.1161\/STROKEAHA.112.671453","article-title":"The incidence of cerebral venous thrombosis: a cross-sectional study","volume":"43","author":"Coutinho","year":"2012","journal-title":"Stroke"},{"key":"10.1016\/j.jtha.2023.06.026_bib40","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1161\/STROKEAHA.116.013617","article-title":"Cerebral venous sinus thrombosis incidence is higher than previously thought: a retrospective population-based study","volume":"47","author":"Devasagayam","year":"2016","journal-title":"Stroke"},{"key":"10.1016\/j.jtha.2023.06.026_bib41","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/ajh.24759","article-title":"Clinical outcomes in a cohort of patients with heparin-induced thrombocytopenia","volume":"92","author":"Kuter","year":"2017","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jtha.2023.06.026_bib42","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1111\/jth.14587","article-title":"The risk of major bleeding in patients with suspected heparin-induced thrombocytopenia","volume":"17","author":"Pishko","year":"2019","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.06.026_bib43","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1055\/s-0040-1712957","article-title":"Comparative analysis of a French prospective series of 144 patients with heparin-induced thrombocytopenia (FRIGTIH) and the literature","volume":"120","author":"Gruel","year":"2020","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.06.026_bib44","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S0002-9343(96)00258-6","article-title":"A\u00a014-year study of heparin-induced thrombocytopenia","volume":"101","author":"Warkentin","year":"1996","journal-title":"Am J Med"},{"key":"10.1016\/j.jtha.2023.06.026_bib45","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1007\/s11239-021-02484-6","article-title":"HIT in the head: a systematic review of cerebral venous sinus thrombosis in classical and autoimmune heparin-induced thrombocytopenia","volume":"52","author":"Bauman","year":"2021","journal-title":"J\u00a0Thromb Thrombolysis"},{"key":"10.1016\/j.jtha.2023.06.026_bib46","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1056\/NEJMoa2109908","article-title":"Clinical features of vaccine-induced immune thrombocytopenia and thrombosis","volume":"385","author":"Pavord","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2023.06.026_bib47","doi-asserted-by":"crossref","first-page":"513","DOI":"10.7326\/M21-4502","article-title":"Case series of thrombosis with thrombocytopenia syndrome after COVID-19 vaccination-United States, December 2020 to August 2021","volume":"175","author":"See","year":"2022","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jtha.2023.06.026_bib48","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/ene.15113","article-title":"Declining mortality of cerebral venous sinus thrombosis with thrombocytopenia after SARS-CoV-2 vaccination","volume":"29","author":"van de Munckhof","year":"2022","journal-title":"Eur J Neurol"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783623005123?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783623005123?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T07:39:54Z","timestamp":1742283594000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783623005123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":48,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S1538783623005123"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2023.06.026","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antibodies against platelet factor 4 and the risk of cerebral venous sinus thrombosis in patients with vaccine-induced immune thrombotic thrombocytopenia","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2023.06.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}